top of page

Interactive Clinical Research Experience

With a robust background in clinical research, I, Anıl Goktas, have honed my skills across various therapeutic areas and trial phases. As a Clinical Research Associate (CRA), I have played a pivotal role in numerous high-profile studies, particularly in oncology, cardiology, and autoimmune diseases.

​

My journey in clinical research began at Medex SMO, where I served as a Site Coordinator, managing Phase III trials with precision. Over the years, I advanced to the role of CRA, contributing to the success of pivotal Phase II and III trials at esteemed organizations like Medex CRO, IQVIA, and Ascot Science.

​

Currently, as a CRA 2 at Medex CRO, I am deeply involved in cutting-edge CAR-T therapy studies and groundbreaking oncology research. My expertise ensures compliance with rigorous regulatory standards, maintaining the highest quality of clinical data.

Passionate about advancing medical science, I continue to engage in transformative research that aims to improve patient outcomes and contribute to the development of innovative treatments.

Test Tüplü Bilim Adamı

CREATE A BETTER WORLD

PHASE 1

  • 2022-2023: DC25-1A CAR-T (Phase I/IIa) Multiple Myeloma - Clinical Research Associate (CRA)

​

  • 2023-Present: MG-001 (Phase Ib/II) - Clinical Research Associate 2

phase1.png
Ayrıntılar

PHASE 3

  • 2023-Present: PZN-127-03 (Phase III) - Clinical Research Associate 2

​

  • 2023-2023: Horizon01 – Lung Cancer (Phase III) - Clinical Research Associate 2

​

  • 2023-2023: INOVA 120-WO41554 Breast Cancer (Phase III) - Clinical Research Associate 2

​

  • 2021-2023: I6T-MC-AMAM - Crohn Disease (Phase III) - Site Coordinator

​

  • 2021-2023: I6T-MC-AMAX - Crohn Disease (Phase III) - Site Coordinator

​

  • 2021-2023: GA29145 (Phase III) - Site Coordinator

​

  • 2021-2023: APD334-303 (Phase III) - Site Coordinator

​

  • 2021-2022: APD334-302 (Phase III) - Site Coordinator

​​

images (2).png
Ayrıntılar

PHASE 2

  • 2024-Present: DC08-SLE-001 CAR-T (Phase IIa) - Clinical Research Associate 2

  • 2023-2024: Intercept 747-214 (Phase IIa) - Clinical Research Associate 2

  • 2022-2023: DC-08 CAR-T (Phase II) - Clinical Research Associate (CRA)

  • 2020-2021: B7981007 (Phase II) - Site Coordinator

  • 2020-2021: B7981005 (Phase II) - Site Coordinator

  • 2021-2023: APD334-202 (Phase II) - Site Coordinator

213-2139696_phase-2-phase-1-icon-transparent-hd-png.png
Ayrıntılar
Özet Çöl

PHASE 3

  • 2021-2022: 261203 (Phase III) - Site Coordinator

​

  • 2021-2023: HS0003 (Phase III) - Site Coordinator

​

  • 2021-2023: TCH-306 (Phase III) - Site Coordinator

​

  • 2021-2021: HS-18-633 (Phase III) - Site Coordinator

  • ​

  • 2021-2021: HS-19-647 (Phase III) - Site Coordinator

​

  • 2020-2023: C3601002 (Phase III) - Site Coordinator

  • ​

  • 2020-2022: CT-P13_3.8 (Phase III) - Site Coordinator

​

  • 2019-2023: AR-301 (Phase III) - Site Coordinator

​

  • 2018-2021: ALX0681-C301 (HERCULES) (Phase III) - Site Coordinator

​

  • 2023-Present: MG-001 (Phase Ib/II) - Clinical Research Associate 2

images (2).png
Ayrıntılar

Frequently asked questions

  • 01
  • 02
  • 03
  • 04
  • 05
Gökhan Dağ – Dag Engineering Founder

Gokhan Dag,
Dag Engineering Founder

Dag Engineering CEO Gokhan Dag Mr.Goktas delivered the solution we needed quickly and effectively. Their professional approach and customer-oriented service really impressed us. We highly recommend them!"

Melike Zeynep Çiftci – Clinical Researcher

Melike Zeynep Ciftci, Clinical Researcher

It was a great pleasure to work with Anıl GOKTAS. Their fast response time and solution-oriented approach made our work easier and enabled us to achieve successful results."

Beyza Bayrak – Project Assistant

Beyza Bayrak, Project Assistant

We were extremely satisfied with the services provided by Anıl Goktas. Thanks to the team's expertise and support, we completed our projects smoothly. Thank you Anıl Goktas!"

bottom of page